Patents by Inventor Susan R. Webb

Susan R. Webb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MHC class II antigen-presenting systems and methods for activating CD4T cells
    Patent number: 7439335
    Abstract: The present invention relates to synthetic antigen-presenting matrices, their methods of making and their methods of use. One such matrix is cells that have been transfected to produce MHC antigen-presenting molecules with one or more accessory molecules. The matrices are used to activate naive CD4+ T cells as well as shift the ongoing activation state into a preferred differentiated population of either Th1 or Th2 cells.
    Type: Grant
    Filed: April 8, 2004
    Date of Patent: October 21, 2008
    Assignee: The Scripps Research Institute
    Inventors: Susan R. Webb, Ola Winqvist, Lars Karlsson, Michael R. Jackson, Per A. Peterson
  • MHC class II antigen-presenting systems and methods for activating CD4T cells
    Patent number: 7402430
    Abstract: The present invention relates to synthetic antigen-presenting matrices, their methods of making and their methods of use. One such matrix is cells that have been transfected to produce MHC antigen-presenting molecules with one or more accessory molecules. The matrices are used to activate naive CD4+ T cells as well as shift the ongoing activation state into a preferred differentiated population of either Th1 or Th2 cells.
    Type: Grant
    Filed: July 29, 2004
    Date of Patent: July 22, 2008
    Assignee: The Scripps Research Institute
    Inventors: Susan R. Webb, Ola Winqvist, Lars Karlsson, Michael R. Jackson, Per A. Peterson
  • MHC class II antigen-presenting systems and methods for activatind CD4+T cells
    Patent number: 7074617
    Abstract: The present invention relates to synthetic antigen-presenting matrices, their methods of making and their methods of use. One such matrix is cells that have been transfected to produce MHC antigen-presenting molecules with one or more accessory molecules. The matrices are used to activate naive CD4+T cells as well as shift the ongoing activation state into a preferred differentiated population of either Th1 or Th2 cells.
    Type: Grant
    Filed: November 17, 2000
    Date of Patent: July 11, 2006
    Assignee: The Scripps Research Institute
    Inventors: Susan R. Webb, Ola Wingvist, Lars Karlsson, Michael R. Jackson, Per A. Peterson
  • MHC class II antigen-presenting systems and methods for activating CD4+ T cells
    Patent number: 6355479
    Abstract: The present invention relates to synthetic antigen-presenting matrices, their methods of making and their methods of use. One such matrix is cells that have been transfected to produce MHC antigen-presenting molecules with one or more accessory molecules. The matrices are used to activate naive CD4+ T cells as well as shift the ongoing activation state into a preferred differentiated population of either Th1 or Th2 cells.
    Type: Grant
    Filed: April 12, 1999
    Date of Patent: March 12, 2002
    Assignee: The Scripps Research Institute
    Inventors: Susan R. Webb, Ola Winqvist, Lars Karlsson, Michael R. Jackson, Per A. Peterson